Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

被引:82
|
作者
Gorny, Miroslaw K. [1 ]
Wang, Xiao-Hong [3 ]
Williams, Constance [1 ]
Volsky, Barbara [1 ]
Revesz, Kathy [3 ]
Witover, Bradley [1 ]
Burda, Sherri [1 ]
Urbanski, Mateusz [1 ]
Nyambi, Phillipe [1 ,3 ]
Krachmarov, Chavdar [4 ]
Pinter, Abraham [4 ]
Zolla-Pazner, Susan [1 ,3 ]
Nadas, Arthur [2 ]
机构
[1] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
[2] NYU, Sch Med, Inst Environm Med, New York, NY 10016 USA
[3] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA
[4] Publ Hlth Res Inst, Newark, NJ 07103 USA
关键词
Immunoglobulin gene usage; Human monoclonal antibodies; Anti-HIV-1; antibodies; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; EXTENSIVE SOMATIC MUTATION; POLYMERASE-CHAIN-REACTION; EQUATORIAL RAIN-FORESTS; MEMORY B-CELLS; MOLECULAR CHARACTERIZATION; TYPE-1; GP120; CORECEPTOR SELECTIVITY; ENVELOPE GLYCOPROTEIN;
D O I
10.1016/j.molimm.2008.09.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human anti-V3 monoclonal antibodies (mAbs) generated from HIV-1 infected individuals display diversity in the range of their cross-neutralization that may be related to their immunogenetic background. The study of the immunoglobulin (Ig) variable region gene usage of heavy chains have shown a preferential usage of the VH5-51 gene segment which was detected in 35% of 51 human anti-V3 mAbs. In contrast, human mAbs against other envelope regions of HIV-1 (anti-Env), including the CD4-binding domain, the CD4-induced epitope, and gp41 preferentially used the VH1-69 gene segment, and none of them used the VH5-51 gene, Furthermore, the usage of the VH4 family by anti-V3 mAbs was restricted to only one gene segment, VH4-59, while the VH3 gene family was used at a significantly lower frequency by all of the analyzed anti-HIV-1 mAbs. Multivariate analysis showed that usage of VH gene segments was significantly different between anti-V3 and anti-Env mAbs, and compared to antibodies from healthy subjects. In addition, the anti-V3 mAbs preferentially used the JH3 and D2-15 gene segments. The preferential usage of selected Ig gene segments and the characteristic pattern of Ig gene usage by anti-V3 mAbs can be related to the conserved structure of the V3 region. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:917 / 926
页数:10
相关论文
共 50 条
  • [1] Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure
    Gorny, Miroslaw K.
    Sampson, Jared
    Li, Huiguang
    Jiang, Xunqing
    Totrov, Maxim
    Wang, Xiao-Hong
    Williams, Constance
    O'Neal, Timothy
    Volsky, Barbara
    Li, Liuzhe
    Cardozo, Timothy
    Nyambi, Phillipe
    Zolla-Pazner, Susan
    Kong, Xiang-Peng
    PLOS ONE, 2011, 6 (12):
  • [2] Induction of Broadly Neutralizing Antibodies against Conserved Epitopes in HIV-1 V3 Domain
    Chen, Deyan
    Wu, Xinlin
    Su, Airong
    Zheng, Nan
    Wu, Zhiwei
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 134 - 134
  • [3] Germline variable genes code for contact residues maintained during affinity maturation of human anti-V3 monoclonal antibodies encoded by VH5-51
    Gorny, M. K.
    Sampson, J.
    Li, H.
    Jiang, X.
    Totrov, M.
    Wang, X.
    Li, L.
    Williams, C.
    Luthra, K.
    Nyambi, P.
    Zolla-Pazner, S.
    Kong, X.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A25 - A25
  • [4] CROSS-REACTING ANTIBODIES INDUCED BY PEPTIDES OF HIV-1 V3 DOMAIN
    BUTTO, S
    MCDANAL, C
    FAUST, A
    GREENWELL, T
    BOLOGNESI, D
    MATTHEWS, T
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 147 - 147
  • [5] Differential induction of antibodies against immunogenic V1V2 and V3 regions of HIV-1 envelope by immune complex vaccines
    Hioe, Catarina E.
    Kumar, Rajnish
    Upadhyay, Chitra
    Fox, Alicia
    Itri, Vincenza
    Peachman, Kristina
    Rao, Mangala
    Jiang, Xungqing
    Kong, Xiangpeng
    Zolla-Pazner, Susan
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [6] Escape of HIV-1 is associated with lack of V3 domain-specific antibodies in vivo
    Schreiber, M
    Muller, H
    Wachsmuth, C
    Laue, T
    Hufert, FT
    VanLaer, MD
    Schmitz, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (01): : 15 - 20
  • [7] REPERTOIRE OF NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES SPECIFIC FOR THE V3 DOMAIN OF HIV-1 GP120
    GORNY, MK
    XU, JY
    KARWOWSKA, S
    BUCHBINDER, A
    ZOLLAPAZNER, S
    JOURNAL OF IMMUNOLOGY, 1993, 150 (02): : 635 - 643
  • [8] Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines
    Kumar, Rajnish
    Tuen, Michael
    Liu, Jianping
    Nadas, Arthur
    Pan, Ruimin
    Kong, Xiangpeng
    Hioe, Catarina E.
    VACCINE, 2013, 31 (46) : 5413 - 5421
  • [9] CORRELATION OF MATERNAL CYTOPHILIC ANTIBODIES AGAINST HIV-1 V3 LOOP PEPTIDES IN INFANTS WITH VERTICAL HIV TRANSMISSION
    WANG, XP
    PAHWA, S
    FASEB JOURNAL, 1994, 8 (04): : A493 - A493
  • [10] MULTIEPITOPE POLYPEPTIDE OF THE HIV-1 ENVELOPE INDUCES NEUTRALIZING MONOCLONAL-ANTIBODIES AGAINST V3 LOOP
    DUARTE, CA
    MONTERO, M
    SERALENA, A
    VALDES, R
    JIMENEZ, V
    BENITEZ, J
    NARCIANDI, E
    MADRAZO, J
    PADRON, G
    SANCHEZ, G
    GILLJAN, G
    PERSSON, K
    OJEDA, S
    CABALLERO, A
    MIRANDA, A
    DOMINGUEZ, MD
    WAHREN, B
    MENENDEZ, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (03) : 235 - 243